Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Virus-specific Cytotoxic T-lymphocytes
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
January 6, 2023
Primary Completion Date
January 31, 2027
Completion Date
January 31, 2027
Last Updated
April 16, 2026
NCT04542733
NCT06926894
NCT02007356
NCT06219616
NCT05511779
NCT05305040
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions